Fiona A. Sharp

4.0k citations

16 papers · 2.1k indexed · 1 hit paper · h-index 11

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
Microbiology top 5%

Papers in ⓘ

Immunology 10
- Immune Response and Inflammation 6
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 4
- Galectins and Cancer Biology 2
Molecular Biology 8
- Inflammasome and immune disorders 5
- CRISPR and Genetic Engineering 2

Co-authors: Ed C. Lavelle (7 shared papers)James Harris (3 shared papers)Emma M. Creagh (4 shared papers)Jürg Tschopp (2 shared papers)Tarek M. Fahmy (3 shared papers)Katherine A. Fitzgerald (1 shared paper)Hardy Kornfeld (1 shared paper)Michelle Hartman (1 shared paper)
Journals: European Journal of Immunology (3 papers)Cancer Research (2 papers)Journal of Biological Chemistry (1 paper)Cell Reports Medicine (1 paper)Nature Immunology (1 paper)
Partner nations: United States Ireland Switzerland

In The Last Decade

Fiona A. Sharp

15 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation 2011 · 664 citations

Peers

Countries citing papers authored by Fiona A. Sharp

Since Specialization

Citations

This map shows the geographic impact of Fiona A. Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona A. Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona A. Sharp more than expected).

Fields of papers citing papers by Fiona A. Sharp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona A. Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona A. Sharp. The network helps show where Fiona A. Sharp may publish in the future.

Co-authors

The 25 scholars most cited alongside Fiona A. Sharp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fiona A. Sharp Line = papers co-authored together Fiona A. Sharp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation Journal of Biological Chemistry ·James Harris, Michelle Hartman, Caitrionna Roche, Shijuan G. Zeng, Amy M. J. O’Shea, Fiona A. Sharp, Eimear M. Lambe, Emma M. Creagh, Douglas T. Golenbock, Jürg Tschopp, Hardy Kornfeld, Katherine A. Fitzgerald, Ed C. Lavelle Hit paper breakdown →	2011	664
2	Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome Proceedings of the National Academy of Sciences ·Fiona A. Sharp, Darren Ruane, Benjamin Claass, Emma M. Creagh, James Harris, Padma Malyala, Manomohan Singh, Derek T. O’Hagan, Virginie Pétrilli, Jürg Tschopp, Luke O'neill, Ed C. Lavelle	2009	437
3	Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response Nature Immunology ·Sara W Montminy, Naseema N. Khan, Sara C. McGrath, Mitchell J. Walkowicz, Fiona A. Sharp, Joseph Conlon, Koichi Fukase, Shoichi Kusumoto, C. Sweet, Kensuke Miyake, Shizuo Akira, Robert J. Cotter, Jon D. Goguen, Egil Lien	2006	314
4	A carbon nanotube–polymer composite for T-cell therapy Nature Nanotechnology ·Tarek R. Fadel, Fiona A. Sharp, Nalini Vudattu, Ragy Ragheb, Justin Garyu, Dongin Kim, Enping Hong, Nan Li, Gary L. Haller, Lisa D. Pfefferle, Sune Justesen, Kevan C. Herold, Tarek M. Fahmy	2014	200
5	Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines Trends in biotechnology ·Stacey L. Demento, Alyssa Siefert, Arunima Bandyopadhyay, Fiona A. Sharp, Tarek M. Fahmy	2011	137
6	The vaccine adjuvant alum inhibits IL‐12 by promoting PI3 kinase signaling while chitosan does not inhibit IL‐12 and enhances Th1 and Th17 responses European Journal of Immunology ·Andrés Mori, Ewa Oleszycka, Fiona A. Sharp, Michelle M. Coleman, Yuki Ozasa, Manmohan Singh, Derek T. O’Hagan, Lidia Tajber, Owen I. Corrigan, Edel A. McNeela, Ed C. Lavelle	2012	115
7	Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen International Journal of Nanomedicine ·Douglas Hanlon, Sandeep Saluja, Fiona A. Sharp, Enping Hong, David Khalil, Robert E. Tigelaar, Tarek M. Fahmy, Richard L. Edelson, Eve Robinson	2014	82
8	The vaccine adjuvant alum promotes IL‐10 production that suppresses Th1 responses European Journal of Immunology ·Ewa Oleszycka, Seán McCluskey, Fiona A. Sharp, Natalia Muñoz‐Wolf, Emily Hams, Aoife L. Gorman, Padraic G. Fallon, Ed C. Lavelle	2018	75
9	Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment Cancer Research ·Hui Qin Wang, Iain J. Mulford, Fiona A. Sharp, Jinsheng Liang, Sema Kurtuluş, Gina M. Trabucco, David S. Quinn, Tyler A. Longmire, Nidhi Patel, Roshani Patil, Matthew D. Shirley, Yan Chen, Hao Wang, David A. Ruddy, Claire Fabre, Juliet Williams, Peter S. Hammerman, Jennifer Mataraza, Barbara Platzer, Ensar Halilovic	2021	43
10	The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants European Journal of Immunology ·James Harris, Fiona A. Sharp, Ed C. Lavelle	2010	41
11	Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles Cell Reports Medicine ·Natalia Muñoz‐Wolf, Ross W. Ward, Claire H. Hearnden, Fiona A. Sharp, Joan A. Geoghegan, Katie O’Grady, Craig P. McEntee, Katharine A. Shanahan, Coralie Guy, Andrew Bowie, Matthew Campbell, Carla B. Roces, Giulia Anderluzzi, Cameron Webb, Yvonne Perrie, Emma M. Creagh, Ed C. Lavelle	2023	22
12	439 Dual modes of action for anti-TIM-3 antibody MBG453 in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML): preclinical evidence for immune-mediated and anti-leukemic activity Regular and Young Investigator Award Abstracts ·Catherine Sabatos-Peyton, Tyler A. Longmire, Lisa Baker, Nidhi Patel, Anne‐Sophie Wavreille, Mélanie Verneret, Pushpa Jayaraman, Xiaomo Jiang, Stephanie Schwartz, Viviana Cremasco, Hongbo Lu, Shumei Qiu, Fiona A. Sharp, Mikael L. Rinne, Glenn Dranoff	2020	7
13	Non‐Canonical Inflammasome Activation Mediates the Adjuvanticity of Nanoparticles SSRN Electronic Journal ·Natalia Muñoz‐Wolf, Ross W. Ward, Claire H. Hearnden, Fiona A. Sharp, Joan A. Geoghegan, Katie O’Grady, Craig P. McEntee, Katharine A. Shanahan, Coralie Guy, Andrew Bowie, Matthew Campbell, Carla B. Roces, Giulia Anderluzzi, Cameron Webb, Yvonne Perrie, Emma M. Creagh, Ed C. Lavelle	2022	6
14	Abstract 5560: PD-1/PD-L1 blockade enhances MDM2 inhibitor activity in p53 wild-type cancers Cancer Research ·Hui Qin Wang, Jinsheng Liang, Iain J. Mulford, Fiona A. Sharp, Swann Gaulis, Yan Chen, Gina M. Trabucco, David S. Quinn, Joseph D. Growney, Matthew J. Meyer, Juliet Williams, Peter S. Hammerman, Francesco Hofmann, Glenn Dranoff, Jeffrey A. Engelman, Jennifer Mataraza, Ensar Halilovic	2018	3
15	255 ExPRESS^TM: An accelerated process for the manufacture of KSQ-001, a CRISPR/Cas9-edited eTIL^TM product Regular and Young Investigator Award Abstracts ·Sharon Lin, Leila J. Williams, Mitali Ghose, Hugh Gannon, Conor Calnan, Angelina Pizzo, Pei-Lun Kao, Mallory Brady, Katri Sofjan, Anne E. Dodson, Sol Shenker, Michael R. Schlabach, Fiona A. Sharp, Frank Stegmeier, Micah J. Benson, Karrie Wong	2022	1
16	297 Manufacture of KSQ-001, a CRISPR/Cas9-engineered TIL (eTIL) therapy, for the treatment of head and neck squamous cell carcinoma Regular and Young Investigator Award Abstracts ·Karrie Wong, Leila J. Williams, Nicholas Constant, Mitali Ghose, Sharon Lin, David Thompson, Conor Calnan, Fiona A. Sharp, Seán Donnelly, Charles T. Quinn, Glenn J. Hanna, Frank Stegmeier, Micah J. Benson	2022	0

About Fiona A. Sharp

Fiona A. Sharp is a scholar working on Immunology, Molecular Biology, Oncology, Genetics and Genetics, having authored 16 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (5 papers), Inflammasome and immune disorders (5 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers), Galectins and Cancer Biology (2 papers), Cancer-related Molecular Pathways (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Immunology (1.1k citations), Microbiology (107 citations), Endocrinology (82 citations), Molecular Biology (1.1k citations) and Epidemiology (519 citations). Fiona A. Sharp has collaborated with scholars based in United States, Ireland and Switzerland. Frequent co-authors include Ed C. Lavelle, James Harris, Emma M. Creagh, Jürg Tschopp, Tarek M. Fahmy, Katherine A. Fitzgerald, Hardy Kornfeld, Michelle Hartman, Amy M. J. O’Shea and Douglas T. Golenbock. Their work appears in journals such as European Journal of Immunology, Cancer Research, Journal of Biological Chemistry, Cell Reports Medicine and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact